Citation Impact
Citing Papers
NACSELD acute‐on‐chronic liver failure (NACSELD‐ACLF) score predicts 30‐day survival in hospitalized patients with cirrhosis
2018
Hepatorenal syndrome: the 8th international consensus conference of the Acute Dialysis Quality Initiative (ADQI) Group
2012
Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: Relationship of serum creatinine to hemodynamics
2010
Diastolic cardiac dysfunction is a predictor of dismal prognosis in patients with liver cirrhosis
2014
Acute kidney injury
2012 Standout
Cardiac dysfunction in patients with cirrhosis
2015
Effects of intravenous albumin in patients with cirrhosis and episodic hepatic encephalopathy: A randomized double-blind study
2013
Hepatocellular carcinoma
2018 Standout
Cardiovascular predictors of death in patients with cirrhosis
2017
Liver cirrhosis
2014
Pathogenesis of Hepatorenal Syndrome: Implications for Therapy
2015
Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: A randomized study
2012
Acute-on chronic liver failure
2012
Renal Failure in Cirrhosis
2009
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis
2015
Acute-on-chronic liver failure in cirrhosis
2016
Acute kidney injury
2019 Standout
Cardiac Function in Patients with Early Cirrhosis during Maximal Beta-Adrenergic Drive: A Dobutamine Stress Study
2014
Cirrhotic cardiomyopathy: pathogenesis and clinical relevance
2013
Albumin: Pathophysiologic basis of its role in the treatment of cirrhosis and its complications
2013
Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial
2015
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
2013 Standout
Hepatorenal syndrome, MELD score and liver transplantation: An evolving issue with relevant implications for clinical practice
2012
Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis
2014
Systolic dysfunction and diastolic dysfunction do not influence medium-term prognosis in patients with cirrhosis
2014
New Consensus Definition of Acute Kidney Injury Accurately Predicts 30-Day Mortality in Patients With Cirrhosis and Infection
2013
Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: A randomized controlled study
2015
Survival at 2 years among liver cirrhotic patients is influenced by left atrial volume and left ventricular mass
2016
Systolic and diastolic dysfunction in cirrhosis: a tissue‐Doppler and speckle tracking echocardiography study
2013
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Increased renal expression and urinary excretion of TLR 4 in acute kidney injury associated with cirrhosis
2012
Infections complicating cirrhosis
2018
Updates on Hepato-Renal Syndrome
2013
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Works of André Nazar being referenced
LEFT ventricular function assessed by echocardiography in cirrhosis: Relationship to systemic hemodynamics and renal dysfunction
2012
Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study
2012
Predictors of Response to Therapy With Terlipressin and Albumin in Patients With Cirrhosis and Type 1 Hepatorenal Syndrome
2009